Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer
Anticancer Research · 2025-05 · 45 (5) · 1935-1951
DOI: 10.21873/anticanres.17571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 28.04.2025. Verfasst von Nan Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi University of Chinese Medicine, Nanning, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Early Growth Response Protein 1, Catechin, Stomach Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. MicroRNAs (miRNAs) are key regulators of tumorigenesis. This study investigated the role of the miR-192/215-early growth response protein 1 (EGR1) axis in GC and explored its therapeutic implications. MATERIALS AND METHODS: Combinatorial molecular approaches including dual-luciferase reporter assays and western blot analyses were employed to authenticate EGR1 as a direct target of miR-192/215. Multi-modal data analysis incorporating The Cancer Genome Atlas datasets and our institutional cohort (n=56) was conducted to delineate EGR1 expression profiles across clinicopathological GC stages. Pharmacological modulation studies were implemented to characterize the dose- and time-dependent effects of epigallocatechin-3-gallate (EGCG) on the miR-192/215-EGR1 axis. RESULTS: EGR1 is a direct target of miR-192/215, with its expression negatively regulated by these miRNAs. Clinical analysis revealed significantly reduced EGR1 expression in tumors of early-stage GC (stage I) and cases with superficial invasion depth (T1) (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi University of Chinese Medicine, Nanning, P.R. China.
- Department of Gastrointestinal Surgery, Shenzhen Second People's Hospital (First Affiliated Hospital of Shenzhen University), Shenzhen, P.R. China.
- Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, P.R. China.
- Department of Ultrasound, Guangdong Women and Children Hospital, Guangzhou, P.R. China.
- Nuclear Medicine Department, Jiangxi Pingxiang People's Hospital, Pingxiang, P.R. China.
- Department of Vascular Surgery, Shenzhen Second People's Hospital (First Affiliated Hospital of Shenzhen University), Shenzhen, P.R. China.
Zitieren
APA
Zhou, N., Yuan, Y., Lin, H., Wang, J., Lin, H., Ashktorab, H., Smoot, D., Jin, Z., Zhuang, S., & Qin, Y. (2025). Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer. Anticancer Research, 45(5), 1935-1951. https://doi.org/10.21873/anticanres.17571
Vancouver
Zhou N, Yuan Y, Lin H, Wang J, Lin H, Ashktorab H, et al. Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer. Anticancer Research. 2025;45(5):1935-1951. doi:10.21873/anticanres.17571
BibTeX
@article{Zhou2025,
author = {Zhou, Nan and Yuan, Yuan and Lin, Huijuan and Wang, Jian and Lin, Huan and Ashktorab, Hassan and Smoot, Duane and Jin, Zhe and Zhuang, Shutong and Qin, Ying},
title = {Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer},
journal = {Anticancer Research},
year = {2025},
volume = {45},
number = {5},
pages = {1935--1951},
doi = {10.21873/anticanres.17571}
}
EUVIMED